Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV-Globulin S in Severe Sepsis or Septic Shock
NCT01315496Phase 3Terminated
- Sponsor
- GC Biopharma
- Start
- Oct 2009
- Primary completion
- Dec 2013
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of NPB-01-ME in sepsis, septic shock, sponsored by GC Biopharma. Started Oct 2009; status: terminated.
02
Drugs
NPB-01-ME
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT01315496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01315496.